Debevoise, Fox Rothschild Rep Lannett In $1.2B Drug Co. Buy

September 2, 2015 – In The News

Fox Rothschild was featured in the Law360 article, “Debevoise, Fox Rothschild Rep Lannett In $1.2B Drug Co. Buy.” Full text can be found in the September 2, 2015, issue, but a synopsis is below.

Fox Rothschild LLP recently helped steer Philadelphia-based generic-drug maker Lannett Company Inc. in a $1.23 billion deal to acquire the U.S. specialty generic drugs unit of Belgian pharmaceuticals company UCB SA.

Lannett said it inked a definitive agreement to buy Princeton, New Jersey-based Kremers Urban Pharmaceuticals Inc. for $1.23 billion in cash upfront, plus potential contingency payments, aiming to diversifying its drug pipeline with drugs for gastroesophageal reflux disease, hypertension and respiratory disease.